Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.3699
-0.0139 (-3.62%)
At close: Nov 18, 2026, 4:00 PM EST
0.3504
-0.0195 (-5.27%)
Pre-market: Nov 19, 2026, 7:58 AM EST
Ensysce Biosciences Market Cap
Ensysce Biosciences has a market cap or net worth of $7.2 million as of November 18, 2026. It is the 42,994th most valuable company in the world and the 5,691st biggest in the United States. Its market cap has increased by 4.31% in one year.
Market Cap
7.20M
Enterprise Value
-22.32M
1-Year Change
4.31%
Global Rank
Country Rank
#5,691 United States
Category
ChartMarket Cap Chart
Since December 1, 2017, Ensysce Biosciences's market cap has decreased from $249.00M to $7.20M, a decrease of -97.11%. That is a compound annual growth rate of -32.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 7.20M | 118.09% |
| Dec 31, 2025 | 3.30M | -68.87% |
| Dec 31, 2024 | 10.60M | 221.21% |
| Dec 29, 2023 | 3.30M | -40.00% |
| Dec 30, 2022 | 5.50M | -95.18% |
| Dec 31, 2021 | 114.00M | 46.34% |
| Dec 31, 2020 | 77.90M | -70.10% |
| Dec 31, 2019 | 260.50M | 6.11% |
| Dec 31, 2018 | 245.50M | -0.89% |
| Dec 29, 2017 | 247.70M | -0.52% |
| Dec 1, 2017 | 249.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vistagen Therapeutics | 8.34M |
| CalciMedica | 8.33M |
| Kyntra Bio | 8.26M |
| MetaVia | 8.24M |
| Immuron | 7.87M |
| Radiopharm Theranostics | 7.67M |
| Addex Therapeutics | 7.10M |
| Exicure | 7.07M |